Allianz Asset Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-900
| Closed | -$233K | – | 2083 |
|
|
2023
Q4 | $233K | Sell |
900
-1,000
| -53% | -$246K | ﹤0.01% | 2034 |
|
|
2023
Q3 | $488K | Sell |
1,900
-1,100
| -37% | -$294K | ﹤0.01% | 1931 |
|
|
2023
Q2 | $855K | Sell |
3,000
-300
| -9% | -$89.3K | ﹤0.01% | 1590 |
|
|
2023
Q1 | $917K | Buy |
3,300
+400
| +14% | +$111K | ﹤0.01% | 1713 |
|
|
2022
Q4 | $803K | Buy |
+2,900
| New | +$819K | ﹤0.01% | 1588 |
|
|
2022
Q2 | – | Sell |
-700
| Closed | -$147K | – | 2271 |
|
|
2022
Q1 | $147K | Buy |
+700
| New | +$152K | ﹤0.01% | 2314 |
|
|
2021
Q4 | – | Sell |
-1,400
| Closed | -$396K | – | 2550 |
|
|
2021
Q3 | $396K | Sell |
1,400
-800
| -36% | -$262K | ﹤0.01% | 2319 |
|
|
2021
Q2 | $762K | Buy |
+2,200
| New | +$666K | ﹤0.01% | 1860 |
|
|
2020
Q3 | – | Sell |
-9,400
| Closed | -$2.52M | – | 1911 |
|
|
2020
Q2 | $2.52M | Sell |
9,400
-18,800
| -67% | -$5.65M | ﹤0.01% | 1517 |
|
|
2020
Q1 | $8.92M | Sell |
28,200
-25,200
| -47% | -$7.65M | 0.01% | 901 |
|
|
2019
Q4 | $15.8M | Buy |
53,400
+20,600
| +63% | +$5.72M | 0.01% | 896 |
|
|
2019
Q3 | $7.64M | Buy |
32,800
+14,500
| +79% | +$3.38M | 0.01% | 1244 |
|
|
2019
Q2 | $4.28M | Buy |
18,300
+2,800
| +18% | +$647K | ﹤0.01% | 1575 |
|
|
2019
Q1 | $3.66M | Buy |
15,500
+11,900
| +331% | +$3.75M | ﹤0.01% | 1599 |
|
|
2018
Q4 | $1.08M | Sell |
3,600
-16,500
| -82% | -$5.27M | ﹤0.01% | 1996 |
|
|
2018
Q3 | $7.1M | Sell |
20,100
-2,200
| -10% | -$757K | 0.01% | 1407 |
|
|
2018
Q2 | $6.47M | Buy |
22,300
+1,400
| +7% | +$394K | 0.01% | 1433 |
|
|
2018
Q1 | $5.72M | Sell |
20,900
-30,200
| -59% | -$9.37M | 0.01% | 1479 |
|
|
2017
Q4 | $16.3M | Buy |
51,100
+7,400
| +17% | +$2.37M | 0.01% | 1078 |
|
|
2017
Q3 | $13.7M | Buy |
43,700
+11,300
| +35% | +$3.35M | 0.01% | 1168 |
|
|
2017
Q2 | $8.79M | Sell |
32,400
-15,300
| -32% | -$4.05M | 0.01% | 1356 |
|
|
2017
Q1 | $13M | Sell |
47,700
-24,300
| -34% | -$6.87M | 0.01% | 1217 |
|
|
2016
Q4 | $20.4M | Buy |
72,000
+16,700
| +30% | +$4.95M | 0.02% | 992 |
|
|
2016
Q3 | $17.3M | Buy |
55,300
+19,000
| +52% | +$5.63M | 0.02% | 1053 |
|
|
2016
Q2 | $8.78M | Buy |
36,300
+19,000
| +110% | +$5.01M | 0.01% | 1293 |
|
|
2016
Q1 | $4.5M | Buy |
17,300
+9,500
| +122% | +$2.51M | 0.01% | 1488 |
|
|
2015
Q4 | $2.39M | Buy |
7,800
+5,600
| +255% | +$1.61M | ﹤0.01% | 1644 |
|
|
2015
Q3 | $642K | Sell |
2,200
-9,700
| -82% | -$3.2M | ﹤0.01% | 1982 |
|
|
2015
Q2 | $4.81M | Buy |
11,900
+5,200
| +78% | +$2.09M | 0.01% | 1397 |
|
|
2015
Q1 | $2.83M | Sell |
6,700
-6,400
| -49% | -$2.52M | ﹤0.01% | 1416 |
|
|
2014
Q4 | $4.45M | Buy |
13,100
+10,500
| +404% | +$3.4M | ﹤0.01% | 1257 |
|
|
2014
Q3 | $860K | Buy |
+2,600
| New | +$857K | ﹤0.01% | 1711 |
|
Other funds holding BIIB
VCM
VPM
Allianz Asset Management's BIIB Position: Q1 2026 in Review
Allianz Asset Management reduced its Biogen (BIIB) stake by 28% in Q1 2026, selling an estimated $12.8M and leaving 178,049 shares worth $32.6M. The position accounts for 0.03% of the portfolio, ranked #459.
Allianz Asset Management first reported a position in BIIB in Q2 2013 and has held it in 52 quarters since. The position peaked at $409M in Q2 2015. 1,004 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Allianz Asset Management held 178,049 shares of Biogen worth $32.6M as of Q1 2026.
- Allianz Asset Management sold 69,673 Biogen shares in Q1 2026, an estimated $12.8M.
- Biogen made up 0.03% of Allianz Asset Management's portfolio in Q1 2026, its #459 holding.
- Allianz Asset Management first reported a position in Biogen in Q2 2013 and has held it in 52 quarters since.
- Allianz Asset Management's Biogen position peaked at $409M in Q2 2015.
- 1,004 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.